Don't miss a thing.

Stay updated by adding The Lotus Cancer Initiative to your home screen.

Android (Chrome): open your browser menu (⋮), select Add to Home screen or Install app, then reopen Lotus from your home screen.

iPhone or iPad (Safari): select Share, choose Add to Home Screen, then open Lotus from your home screen.

Then: select Enable notifications below and allow alerts when your device asks.

← Back to Journal The Lotus Cancer Initiative Inc.

Did you know?

Did you know? Bilateral Salpingectomy (BS) — the removal of both fallopian tubes — is increasingly recommended for women who have completed their families and are undergoing pelvic surgery or seeking permanent…

By Admin

Did you know?

Bilateral Salpingectomy (BS) — the removal of both fallopian tubes — is increasingly recommended for women who have completed their families and are undergoing pelvic surgery or seeking permanent contraception.

Research suggests that many high-grade serous ovarian cancers, the most common and aggressive type of ovarian cancer, may actually begin in the fallopian tubes. Removing the tubes can significantly reduce the risk of developing ovarian cancer while preserving the ovaries and their hormonal function.

Talk to your healthcare provider about whether bilateral salpingectomy may be an option for you.

Prevention is one of our strongest tools in the fight against ovarian cancer.